FDA Approves Injectable Lenacapavir as Long-Acting HIV Prevention Option:

FDA Approves Injectable Lenacapavir as Long-Acting HIV Prevention Option:

Daily Current Affairs   /   FDA Approves Injectable Lenacapavir as Long-Acting HIV Prevention Option:

Change Language English Hindi

Category : Science and Tech Published on: June 21 2025

Share on facebook

The U.S. FDA has approved injectable lenacapavir as a semiannual HIV prevention method. This follows positive outcomes from PURPOSE 1 & 2 clinical trials in 2024. The WHO welcomed the move, highlighting it as a significant step in expanding HIV prevention options with a long-acting, convenient alternative for vulnerable populations.

Recent Post's

  • Sanjay Seth to inaugurate India’s first International Ophthalmology Research Conference (AIOS-AFOU 2026) on May 9-10 at Delhi Cantonment.

    Read More....

  • Mother’s Day 2026 to be celebrated on May 10 with the theme “The Great Unburdening”.

    Read More....

  • Indore to host BRICS Agriculture Ministers’ Meeting in June 2026 under India’s BRICS Presidency.

    Read More....

  • World Thalassemia Day 2026 observed on May 8 with the theme ‘Hidden No More: Finding the Undiagnosed’.

    Read More....

  • Bengaluru records highest suicide rate among major Indian cities at nearly 20 per lakh population.

    Read More....

  • World Ovarian Cancer Day 2026 observed on May 8 with the theme “No Woman Left Behind”.

    Read More....

  • World Red Cross Day 2026 celebrated on May 8 with the theme ‘Keeping Humanity Alive’.

    Read More....

  • IndiaAI signs MoU with ICMR to boost AI-driven healthcare innovation and research.

    Read More....

  • The nation celebrates the 165th birth anniversary of Rabindranath Tagore on May 7, 2026.

    Read More....

  • DRDO successfully tests indigenous TARA glide weapon systems from Jaguar aircraft.

    Read More....